comparemela.com

Page 27 - David Adlington News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SMITH & NEPHEW, PLC (SNN) Q1 2021 Earnings Call Transcript

Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Siemens Healthineers AG (Other OTC: SEMHF)

Markets Sanofi (SNYNF) In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Sanofi, with a price target of EUR93.00. The company’s shares closed last Friday at $102.96. Vosser has an average return of 3.3% when recommending Sanofi. According to TipRanks.com, Vosser is ranked #1271 out of 7474 analysts. Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $116.62, implying a 13.3% upside from current levels. In a report issued on April 12, Goldman Sachs also maintained a Buy rating on the stock with a EUR101.00 price target. Siemens Healthineers AG (SEMHF)

Siemens Healthineers AG (SEMHF) Gets a Buy Rating from J P Morgan

According to TipRanks.com, Adlington is ranked #6968 out of 7459 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Siemens Healthineers AG with a $60.23 average price target, an 8.0% upside from current levels. In a report issued on April 19, Kepler Capital also upgraded the stock to Buy with a EUR52.00 price target. Siemens Healthineers AG’s market cap is currently $62.84B and has a P/E ratio of 31.40. The company has a Price to Book ratio of 33.94. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Gerresheimer-Aktie schwach: Analysten bemängeln Ergebnisqualität « Finanzportal financial de – Aktien – Börse – Kurse – Rohstoffe

Gerresheimer-Aktie schwach: Analysten bemängeln Ergebnisqualität « Finanzportal financial de – Aktien – Börse – Kurse – Rohstoffe
financial.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financial.de Daily Mail and Mail on Sunday newspapers.

FRESENIUS SE : JP Morgan reiterates its Buy rating

Message : Required fields In a research note published by David Adlington, JP Morgan advises its customers to buy the stock. The target price is unchanged at EUR 50. © MarketScreener with dpa-AFX Analyser 2021 All news about FRESENIUS SE & CO. KGAA 03/18

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.